Phacilitate Leaders World

register for plw

Registration

Registration

The registration for Phacilitate Leaders World 2019 and World Stem Cell Summit 2019 is live now!

TICKET TYPE EARLY BIRD RATE
(ends Nov 30th)
STANDARD RATE
(until January 21st)
ONSITE RATE
(January 22nd-25th)
Academic / Government / Regulator / NFP / Blood bank / Clinician / Patient advocate  $895 $995 $1,495
Pharma/ Biotech / CRO/ Investor/ Analyst $2,595 $2,795 $3,195
Technology or Tools or Service Provider/ Consultant/ Lawyer $3,495 $3,495 $3,995
Visitor pass (exhibition only) $545 $545 $945 
Media/Press Pass  Free Free Free
Student Pass $545 $545 $945 

 

Which ticket should I purchase?

  


 

Optional add-ons

Advanced Therapies Summit in association with Fierce Biotech *

Pre-event: $150

Onsite:
$150

* subject to availability

Yacht
Party *

Pre-event: $200

Onsite: 
$300

* subject to availability

Stem Cell and Regenerative Medicine Action Awards *

Pre-event: $200

Onsite: 
$300

* subject to availability

 PLW 2019

 

wscs 2019

 

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK